Article Listing - Celgene's Revlimid approved in China for MM; gets PDUFA date in USA for mantle cell lymphoma
SALMON CALCITONIN ASSAY FROM CORTECS
10 February 1992
UK company Cortecs Diag-nostics has developed an enzyme immunoassay for salmon calcitonin which employs an improvement on procedural format with...
STERLING WINTHROP
10 February 1992
Sterling Winthrop has named Christopher Coughlin as chief financial officer, succeeding George Benjamin, who has retired.
B-MS SCHOOL OF PUBLIC HEALTH
10 February 1992
US concern Bristol-Myers Squibb is to fund its school of public health for a period of five years to the...
ASTRA/T CELL SCIENCES DEAL
10 February 1992
Astra of Sweden and T Cell Sciences in the USA have concluded the agreement first set up last year (Marketletter...
FRENCH HEALTH SPENDING SURPLUS
10 February 1992
The French social security budget is expecting to post a deficit of only 2 billion French francs ($364.3 million), this...
ROMANIAN MEDICINES TO RUSSIA
10 February 1992
Romania is to export unspecified quantities of medicines and drugs to the Russian Federation this year, following the signing of...
APPROVAL SETBACK FOR US BIOSCIENCE
10 February 1992
The US Food and Drug Administra-tion's Oncologic Drugs Advisory Committee has declined to recommend marketing approval of US Biosci-ence Inc's...
US APPROVAL FOR WELLCOME'S MIVACRON
10 February 1992
The US Food and Drug Administr-ation has granted marketing approval for Burroughs Wellcome's Mivacron (mivacurium chloride) to be used as...
CORTEX IN STROKE TREATMENT JV
10 February 1992
Two US biotechnology companies have agreed to develop potential treatments for stroke and other acute degenerative brain disorders. Cortex Pharmaceuticals...
FOURNIER PLANS GROWTH ABROAD
10 February 1992
French pharmaceutical group, Laboratoire Fournier, is planning foreign expansion following its failure to acquire Delagrange, which was finally acquired by...
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
